UTHR Exercise Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Sep 8, 2026
Exercise
Calculated transaction value
$0
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Sep 4, 2026
Public filing date
Sep 8, 2026
Filing lag
Filed 4 days later
UTHR daily price context
Close on/before transaction
$487.61
Sep 4, 2026
Close before public filing
$487.61
Sep 7, 2026
Return since public filing
+1.95%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option on Common Stock
- Quantity / price
- 9,500 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001106578-26-000136
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$5.77M
Buys / sales
0 / 7
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Sep 4, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Sep 4, 2026 | $19.43K |
| United Therapeutics Corp UTHR | Sale | Sep 4, 2026 | $108.57K |
| United Therapeutics Corp UTHR | Sale | Sep 4, 2026 | $1.38M |
| United Therapeutics Corp UTHR | Sale | Sep 4, 2026 | $1.68M |
| United Therapeutics Corp UTHR | Sale | Sep 4, 2026 | $741.87K |
| United Therapeutics Corp UTHR | Sale | Sep 4, 2026 | $569.48K |
| United Therapeutics Corp UTHR | Sale | Sep 4, 2026 | $157.34K |
| United Therapeutics Corp UTHR Current | Exercise | Sep 4, 2026 | $0 |